All Industries

Top Diagnostics Companies

116 Diagnostics companies, sorted by total funding raised.

116

Companies

$9.8B

Combined Funding

3

Funded (Last 60d)

Seed

Top Stage

Indexed tracks 116 Diagnostics companies that have collectively raised $9.8B in documented funding. The most-funded diagnostics companies tracked include Caris Life Sciences and Ginkgo Bioworks. 3 companies closed a new round in the last 60 days, with Seed being the most common funding stage.

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
Ginkgo BioworksIPO

Our mission is to make biology easier to engineer.

Boston, United States501–1000Automation, Diagnostics
Extension Round·$790.0M·May 2020
Function Health

Whole body lab and imaging platform for longitudinal biomarker tracking and early detection

Austin, United States201–500Diagnostics, Healthcare
Series B·$687.0M·Apr 2026
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
LetsGet CheckedMerged

Providing tools to manage health from home

Dublin, Ireland501–1000Diagnostics, Healthcare
Series F·$448.0M·Jan 2025
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series C·$435.0M·Jun 2021
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Biotech, Diagnostics
Venture Round·$406.0M·Mar 2026
TE
Thrive Earlier DetectionClosed

Liquid biopsy cancer screening company integrating multi-cancer early detection into routine medi...

Cambridge, United States51–200Biotech, Diagnostics
Series B·$367.0M·Jul 2020
DELFI Diagnostics

Develops blood-based liquid biopsy tests using fragmentomics and machine learning to detect and m...

Baltimore, United States51–200Artificial Intelligence, Biotech
Venture Round·$364.8M·Dec 2025
NateraIPO

Natera provides DNA testing across multiple clinical areas including women’s health and oncology.

San Carlos, United States5001–10000Diagnostics, Genomics
Series E·$310.1M·Jul 2019
Harrison.ai

Clinician-led company building AI diagnostic and workflow tools for radiology and pathology, serv...

Sydney, Australia201–500Artificial Intelligence, Diagnostics
Series C·$285.1M·Feb 2025
Alamar Biosciences

Precision proteomics company providing automated, ultra-high sensitivity protein analysis platfor...

Fremont51–200Biotech, Diagnostics
Convertible·$258.0M·Jan 2026
Personal Genome DiagnosticsAcquired

Innovative genomic technologies to solve fundamental challenges in oncology

Baltimore, United States51–200Biotech, Cancer Diagnostics
Series C·$244.2M·Feb 2021
Truvian

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

San Diego, United States51–200Life Sciences, Diagnostics
Growth Equity·$206.1M·Jul 2024
Scipher Medicine

Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...

Boston, United States51–200Artificial Intelligence, Drug Discovery
Series D·$197.8M·Jul 2024
Visby Medical

A device platform that aims to redefine the way we test and treat illness

Tokyo, United States51–200Healthcare, Diagnostics
Venture Round·$195.7M·Jun 2025
Cytovale

Medical diagnostics company focused on advancing early detection technologies to diagnose fast-mo...

San Francisco, United States51–200Diagnostics, Healthcare
Series D·$191.4M·Oct 2024
Binx Health

Point-of-care diagnostics company enabling rapid STI testing at clinics and urgent care centers.

United StatesDiagnostics, Healthcare
Series F·$169.0M·Apr 2024
Redcliffe Lifetech

Redcliffe Labs is India's Largest Omni-channel Diagnostics platform

Delhi, India1001–5000Diagnostics, Digital Health
Series C·$151.9M·Sep 2024
Clear Labs

Clear Labs provides food analytics while standardizing molecular food quality the global molecula...

San Francisco, United States51–200Food & Beverage, Genomics
Series D·$150.2M·Dec 2024
New Horizon HealthIPO

China-based biotech developing early-stage colorectal and cancer screening diagnostic products us...

Hangzhou, China51–200Healthcare, Diagnostics
Series E·$136.0M·Jul 2020
Berry GenomicsIPO

Leading Chinese genomics company specializing in NGS-based genetic testing for reproductive healt...

Beijing, China201–500Healthcare, Genomics
Series B·$129.8M·Jan 2020
AI Medical Services

Japanese medtech company developing AI-powered endoscopy diagnostic tools to detect gastrointesti...

Tokyo, JapanArtificial Intelligence, Diagnostics
Series B·$121.9M·Oct 2019
SunBird BioMerged

Develops blood-based protein diagnostics for earlier, more accurate diagnosis and monitoring of A...

Cambridge, United States11–50Biotech, Diagnostics
Series B·$108.2M·Oct 2024
MeMed

MeMed is an Israeli medtech company developing rapid host-immune response diagnostics to distingu...

Haifa, Israel51–200Biotech, Diagnostics
Growth Equity·$107.1M·May 2026

Frequently Asked Questions

How many Diagnostics companies are tracked on Indexed?

Indexed tracks 116 Diagnostics companies, sorted by total funding raised.

How much funding have Diagnostics companies raised in total?

The Diagnostics companies tracked by Indexed have collectively raised $9.8B in documented funding.

What are the top-funded Diagnostics companies?

The most-funded Diagnostics companies tracked include Caris Life Sciences, Ginkgo Bioworks, Function Health.

Who are the top investors in Diagnostics?

Leading investors active in Diagnostics include Polaris Partners, NFX, Bain Capital Life Sciences.

Explore More

Other Industries